Kurt Gustafson
Director of Finance/CFO at OMNIAB, INC.
Net worth: 1 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Foehr | M | 51 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Robert Bradway | M | 61 | 18 years | |
| Bassil Dahiyat | M | 53 | 27 years | |
| Charles Berkman | M | 55 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| John Higgins | M | 54 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Joshua Tamaroff | M | 38 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Sarah Boyce | F | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Carolyn Bertozzi | M | 57 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Jennifer Cochran | M | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Ellen Feigal | M | 69 | 10 years | |
| Nancy Valente | M | 66 | 2 years | |
| Nora Brennan | F | 55 | 4 years | |
| Todd Pettingill | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Esteban Santos | M | 56 | 17 years | |
| Kevin Gorman | M | 66 | 7 years | |
| Wing Tak Yu | F | 48 | 7 years | |
| Keith M. McGahan | M | - | 8 years | |
| Jeremy Grunstein | M | - | 21 years | |
| Celia Eckert | F | 52 | 5 years | |
| Marie-Cecile van de Lavoir | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Gary Ng | M | 52 | 3 years | |
| Ann Cohen | F | 63 | 2 years | |
| David Reese | M | 61 | 19 years | |
| Dagmar Rosa-Bjorkeson | F | 60 | 5 years | |
| Kristin Patrick | F | 53 | 2 years | |
| Richard J. Ranieri | M | 71 | 7 years | |
| Steven Rubin | M | 63 | 7 years | |
| Matthew Posard | M | 56 | 11 years | |
| Robert Eckert | M | 69 | 21 years | |
| Alan Bruce Montgomery | M | 70 | 9 years | |
| Matthew Busch | M | 50 | 20 years | |
| Steven Love | M | 55 | 1 years | |
| John Desjarlais | M | 59 | 23 years | |
| David Szymkowski | M | 60 | 22 years | |
| Mike Zahigian | M | - | 23 years | |
| Barbara Klencke | M | 66 | 1 years | |
| Kirk Rosemark | M | - | - | |
| Charles Liles | M | - | - | |
| Dane Leone | M | - | - | |
| Raphael Clynes | M | - | 7 years | |
| Jennifer Sandoz | F | - | - | |
| Andrew Shao | M | - | 4 years | |
| Donna Ventura | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Riga | M | 48 | 10 years | |
| Joseph W. Turgeon | M | 66 | 9 years | |
| Thomas C. Varvaro | M | 54 | 13 years | |
| Rajesh Shrotriya | M | 79 | 17 years | |
| William Ashton | M | 73 | 22 years | |
| Jonathan Lim | M | 52 | 7 years | |
| Stephen R. Allen | M | - | 4 years | |
| Paul Eisenberg | M | - | 14 years | |
| Madhavan Balachandran | M | 73 | 20 years | |
| Kevin Farr | M | 66 | - | |
| Sunil Patel | M | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 1 years |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| John Smither | M | 71 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | 6 years |
| Alex Worsham | M | - | 5 years | |
| John Kuch | M | 64 | 24 years | |
| Elly Ryu | F | 43 | 10 years | |
| David W. Beier | M | 75 | 10 years | |
| Michael Kelly | M | 67 | 14 years | |
| Pamela Wapnick | F | 58 | 9 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Troy Allen Rhonemus | M | 51 | 5 years | |
| Kevin Sharer | M | 76 | 20 years | |
| Dennis Fenton | M | 72 | 27 years | |
| Lloyd Rowland | M | 67 | 3 years | |
| Joseph Newell | M | 54 | 7 years | |
| Anton G. Gueth | M | 67 | 1 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| David J. Scott | M | 71 | - | |
| James Daly | M | 63 | 9 years | |
| Dolatrai Vyas | M | 80 | 9 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Frank Herringer | M | 81 | 15 years | |
| Michael Severino | M | 58 | 10 years | |
| Gregory L. Tewalt | M | - | - | |
| Diana McKenzie | F | 59 | 12 years | |
| Sean B. W. Martin | M | 61 | - | |
| Krishan K. Arora | M | 83 | 3 years | |
| Ricardo J. Gonzalez | M | 53 | 6 years | |
| Vance D. Coffman | M | 79 | 9 years | |
| James E. Cartoni | M | - | 3 years | |
| Jerry D. Choate | M | 86 | - | |
| Bruce Carter | M | 80 | 8 years | |
| J. Reason | M | 83 | 12 years | |
| Harry F. Hixson | M | 84 | 6 years | |
| Alan C. Mendelson | M | 76 | 1 years | |
| Bernice Welles | M | 71 | - | |
| Jonathan Fleming | M | 66 | 2 years | |
| Judith C. Pelham | F | 78 | 22 years | |
| Stephen Block | M | 79 | 15 years | |
| Yujiro Hata | M | 49 | 7 years | |
| Robert F. Baltera | M | 58 | 4 years | |
| David Baltimore | M | 86 | 21 years | |
| François de Carbonnel | M | 78 | 10 years | |
| Frederick Gluck | M | 88 | 13 years | |
| Frans Gustaf Wuite | M | 64 | - | |
| Frank J. Biondi | M | 79 | 15 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
| Netherlands | 1 | 1.01% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kurt Gustafson
- Personal Network
